new york magazine best doctors 2020

New York Magazine Names New York Metro Area’s Best Doctors 2020

We are proud to announce that 32 New Jersey Urology physicians have been honored as New York Magazine’s 2020 Best Doctors in Urology.

The New York Metro Area is home to some of the most prominent and sought after physicians in the country. New York Magazine works with Castle Connolly Medical Ltd., a New York City-based research and information company, who selects the top 10 percent of the region’s physicians by conducting a peer-reviewed survey. Licensed physicians vote for the doctors they view as exceptional, and the Castle Connolly physician-led research team tabulates the results and vets the nominee pool, confirming the doctors’ board certifications and licensing, and investigating their disciplinary histories.

Congratulations to our esteemed urologists from our multiple locations right here in New Jersey!

 

2020 NEW YORK MAGAZINE BEST DOCTORS (Full List):

Mutahar Ahmed, MD
Andrew Bernstein, MD
Rahuldev Bhalla, MD
Thomas Christiano, MD
Thomas Chun, MD
Michael Esposito, MD
Mark Fallick, MD
Joshua Fiske, MD
Glen Gejerman, MD
Martin Goldstein, MD
Steven Katz, MD 
George Klafter, MD
Vincent Lanteri, MD
Bernard Lehrhoff, MD
Gregory Lovallo, MD
Daniel Lowe, MD
Eric Margolis, MD
Mark Miller, MD
Thomas Mueller, MD
Marcella Nachmann, MD
Adam Perzin, MD
Ravi Rajan, MD 
Steven L. Richards, MD
Kenneth Ring, MD
Gene Rosenberg, MD
Frank Salvatore, MD
Domenico Savatta, MD
Eric Seaman, MD
Andrew Siegel, MD
Robert B. Simon, MD
Alan Strumeyer, MD
Gary Wasserman, MD 

 

The complete list of NJU Best Doctors can be viewed here  >

Philadelphia Magazine Top Doctors 2020

NJU Physicians Selected as Philadelphia Magazine 2020 Top Doctors

4 May 2020 News

We’re proud to announce that five New Jersey Urology physicians have been honored as Philadelphia Magazine 2020 Top Doctors in Urology. These physicians were nominated by their peers as the very best in their field, and were carefully screened and vetted for educational and professional experience before being selected.

Philadelphia Magazine 2020 Top Doctors:

View Philadelphia Magazine’s complete list of Top Doctors > https://bit.ly/2xYmooI 

Telemedicine

Introducing Telemedicine Services for Our Patients

We are all living in unprecedented times, and understand why you may have missed or cancelled your scheduled appointment. Please know that it is also extremely important to us that you continue to receive the care you need even during this difficult time.

With this in mind, New Jersey Urology (NJU) has developed a solution that protects both our patients and our staff. As an alternative to an in-person office visit, NJU is now offering telemedicine services effective immediately. Telemedicine can be done through the comfort of your home allowing your physician to provide a “virtual” visit through your phone or computer.

The Centers for Medicare & Medicaid Services have broadened access to Medicare telemedicine services, and major insurance companies have waived referrals and copay fees and obligations. Please check with your insurance provider as it relates to your individual situation.

“New Jersey Urology is excited to offer the convenience of telemedicine services to our patients. We want to empower our patients and give them the tools they need to manage their health amid the fluid situation we are all experiencing with the COVID-19 threat,” said Scott Ciccarelli, CEO of NJ Urology.

What You Need To Know

  • To limit the exposure of COVID-19, the Centers for Medicare & Medicaid Services (CMS) have broadened access to Medicare telemedicine services.

  • Major insurance companies have waived referrals and copay fees and obligations for telemedicine services (co-pay for other services will still apply).

How To Schedule a Virtual Visit

Call to schedule an appointment and inform the doctor’s office that you are interested in scheduling a virtual visit. You will receive email instructions to get set up. It’s that simple!

We will continue to provide best-in-class urologic care for our patients while taking preventative measures to help contain the community spread of this virus. Together, we will get through these challenging times.

Please contact us to learn more about our telehealth services.

Be well and stay safe!


Bergen County Top Docs 2020

Bergen Magazine Names Bergen County’s Top Docs 2020

We are proud to announce that 7 New Jersey Urology physicians have been honored as 2020 Bergen County’s Top Doctors by BERGEN Magazine.

Bergen County is home to some of the most prominent and sought-after physicians in the country. BERGEN magazine commissioned Professional Research Services (PRS) of Troy, Michigan to select the finalists. All final honorees were fact-checked with the State of New Jersey and the New Jersey Division of Consumer Affairs License Verication System.

Congratulations to our esteemed urologists from our Englewood, and Maywood / Teaneck locations!

 

2020 BERGEN COUNTY’S TOP DOCS:

See BERGEN Magazine’s complete list of Urology doctors here >

Dr. Adam Perzin Designated as Urolift® Center of Excellence

18 Feb 2020 News

We’re proud to announce that the New Jersey Urology office of Dr. Adam Perzin in Burlington County has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Perzin has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“Dr. Perzin has earned the UroLift Center of Excellence designation for his dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit.

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift System
The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at www.UroLift.com.

About NeoTract | Teleflex Interventional Urology
A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at www.NeoTract.com.

About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit www.teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

New Jersey Urology Partners with Urology Care Alliance

2 Dec 2019 News

The partnership creates largest urology network in the United States

Bloomfield, NJ: New Jersey Urology (“NJU”), the leading urology service provider in New Jersey, and Urology Management Associates (“UMA”) are pleased to announce a partnership with Urology Care Alliance (“UCA”), effective December 1, 2019.

The partnership creates the largest urology group in the tri-state area, with 155 providers in 60 locations, including six cancer treatment centers. Combined, the organizations will have more robust resources for patients and employees alike and be able to better serve patients in central New Jersey and eastern Pennsylvania. UCA physicians will continue to provide care in their existing offices serving Mercer, Middlesex, Monmouth, and Somerset Counties in New Jersey, and Bucks County in Pennsylvania.

“We are proud to welcome Urology Care Alliance (UCA) to the NJU family,” Scott Ciccarelli, Chief Executive Officer at UMA, said. “Their innovative practices, centralized locations, and best-in-class urology care increases our ability to provide outstanding patient care. With the addition of UCA’s treatment center, NJU now has six state-of-the-art cancer treatment centers across the state. Our rapid growth validates NJU as a leader in comprehensive urologic services that enables outstanding patient outcomes and facilitates practice growth.”

UCA President Dr. Gary Karlin said, “Urology Care Alliance is looking forward to joining New Jersey Urology. This merger will allow us to continue to offer the finest urologic patient care and expand our services in this ever-changing field of urological medicine.”

UCA CEO Alan Plotkin added, “Joining forces with New Jersey Urology is a great opportunity to continue to grow our practice and to remain a strong urologic and cancer treatment presence in central New Jersey and Bucks County, Pennsylvania.”

The Bloom Organization served as buy-side advisor to UMA. Henry Bloom, founder of The Bloom Organization, said, “We are pleased to be able to support the growth of NJU and UMA and look forward to continuing to build the leading platform in the urology industry.”

NJU welcomes the UCA physicians: Saad Antoun, MD; Alex Arnouk, MD; Akwasi Boateng, MD; Phillip Brackin Jr., MD; Doh Cha, MD; Michael Cohen, MD; William Ding, MD; Jarad Fingerman, DO; Marc Feder, MD; Russell Freid, MD; Drew Hecht, DO; Gary Karlin, MD; Alex Kirshenbaum, MD; David Koota, MD; Steven Orland, MD; Matthew Pagano, MD; Ravi Rajan, MD; Steven Richards, MD; Emad Rizkala, MD; Christopher Schaefer, DO; Marc Schwarzman, MD; Troy Sukkarieh, MD; Deep Trivedi, MD; John Watson, MD; Akira Yamamoto, MD; Vitaly Zholudev, MD.


About Urology Management Associates:

Urology Management Associates was formed in August 2018 to provide administrative services to New Jersey Urology. The establishment of UMA enables NJU to continue to focus on providing world-class urology services while remaining a physician-led organization. UMA plans to partner with additional urology groups to provide administrative practice management services initially in the greater New York metropolitan area with long-term plans to expand nationally.

About The Bloom Organization:

Bloom has been advising physicians on transactions since 1990. Founded and lead by Mr. Henry Bloom, the Company is based in Aventura, FL and serves clients nationwide. Bloom’s investment banking expertise is in the healthcare services sector.

NJ Monthly Top Doctors 2019

NJU Physicians Selected as New Jersey Monthly 2019 Top Doctors

We’re proud to announce that 12 New Jersey Urology physicians have been honored as 2019 Jersey Choice Top Doctors by New Jersey Monthly Magazine.

More than 25,000 New Jersey–based doctors were invited to recommend the physicians they would choose to treat their own family members.

2019 Jersey Choice Top Doctors in Urology:

See New Jersey Monthly’s complete list here >

Dr. Jason Wynberg Urologist Bayonne NJ

NJU Welcomes New Urologist Dr. Jason Wynberg

1 Oct 2019 News

NJU is pleased to welcome Dr. Jason Wynberg to our practice! Coming to us from Detroit, MI, Dr. Wynberg most recently served as the Chief of Urology at Sinai-Grace hospital. He is an expert in robotic surgery, complex penile implant surgery, complex kidney stone surgery, and the surgical management of prostate enlargement. Dr. Wynberg is board certified by the American Board of Urology and is a Fellow of the American College of Surgeons.

Dr. Wynberg has been invited to speak and perform live surgical demonstrations at international urology conferences in Paris, Istanbul, and India. He is a member of the American Urological Association, the Societe Internationale d’Urologie, and the Endourological Society.

Dr. Wynberg is committed to excellence in the entirety of patient care, especially surgical outcomes, building a warm relationship with patients, and providing great accessibility to both the patient and their primary care physician. He specializes in robotic surgery, complex kidney stone disease, surgical andrology, and prostate disease.

He will see patients at our Denville office.

Premier Urology Group LLC logo

New Jersey Urology Partners with Premier Urology Group

18 Sep 2019 News

The partnership creates largest urology network in the northeast

New Jersey Urology (“NJU”), the leading urology service provider in New Jersey, and Urology Management Associates (“UMA”) are pleased to announce a partnership with Premier Urology Group LLC (“Premier”), effective September 13, 2019.

The partnership creates one of the largest urology groups in the United States, with 124 providers in 52 locations, including five cancer treatment centers. Combined, the organizations will have more robust resources for patients and employees alike and be able to better serve patients in northern and central New Jersey.

“We are very excited to welcome them as partners,” Scott Ciccarelli, Chief Executive Officer at UMA, said. “Their innovative practices and prime location strengthen NJU’s ability to provide high quality care offerings to all patients across New Jersey.”

Premier physician Dr. Benjamin Fand said, “We have been committed to providing cutting-edge, compassionate urologic care for more than 55 years. Partnering with the NJU platform is an exciting opportunity for us to leverage their extensive resources and expand our range of clinical services.”

Premier physician Dr. Kenneth Ring added, “The integration of our practice with NJU will allow our patients access to the latest technological breakthroughs in the fields of urological oncology, stone disease, enlarged prostate (BPH), voiding dysfunction and incontinence in women and men, and pediatric urology. We are thrilled to join the team and look forward to continuing to provide best-in-class care to our growing patient base.”

The Bloom Organization served as a sell-side advisor to the Premier physician owners. Henry Bloom, founder of The Bloom Organization, said, “NJU and Premier physicians have long standing relationships with one another through their work in the New Jersey communities. I am thrilled to see these two groups come together and excited to witness the building of the country’s preeminent urology group.”

NJU welcomes the Premier physicians: Andrew Bernstein, MD; Benjamin Fand, MD, FACS; Joshua Fiske, MD; Michael Lasser, MD; Bernard Lehrhoff, MD; Alon Mass, MD; Mark Miller, MD; Zein Nakhoda, MD; Rupa Patel, MD; Kenneth Ring, MD; Malcom Schwartz, MD; Neil Sherman, MD; William Terens, MD; and Joshua Wein, MD, FACS. Premier physicians will continue to provide care in their existing offices serving Union, Essex, Hudson, Cranford, Edison and Old Bridge communities.

Wilentz, Goldman & Spitzer served as legal counsel for Premier. McDermott Will & Emery LLP advised UMA.

About Urology Management Associates:

Urology Management Associates was formed in August 2018 to provide administrative services to New Jersey Urology. The establishment of UMA enables NJU to continue to focus on providing world-class urology services while remaining a physician-led organization. UMA plans to partner with additional urology groups to provide administrative practice management services initially in the greater New York metropolitan area with long-term plans to expand nationally.

About The Bloom Organization:

Bloom has been advising physicians on transactions since 1990. Founded and lead by Mr. Henry Bloom, the Company is based in Aventura, FL and serves clients nationwide. Bloom’s investment banking expertise is in the healthcare services sector.

NJU to Host Annual ZERO Prostate Cancer 5k Run/Walk this Fall

11 Sep 2019 News

New Jersey Urology is proud to present South Jersey’s ZERO Prostate Cancer Run/Walk to help end prostate cancer.

When: Sunday, November 3rd | 9 a.m.
Where: Valenzano Winery (1090 Route 206, Shamong, NJ 08088)

The 2019 ZERO Prostate Cancer Run/Walk – South Jersey features a 5K run/walk, 1-mile walk, Kids’ Superhero Dash for Dad, and virtual Snooze for Dudes program. Stick around for the family-friendly post-race celebration. Run/walk participants will receive shirts, free food and prizes, and the opportunity to connect with others who are impacted by prostate cancer. 5K and 1 Mile participants 21 and over (must show valid id) will receive a free wine glass and wine on race day.

The funds raised from 2019 ZERO Prostate Cancer Run/Walk – South Jersey are invested around the country to provide research for new prostate cancer treatments, free prostate cancer testing, and education for men and families about prostate cancer. No other prostate cancer charity spends more per dollar on programs – more than 85 cents. ZERO puts every donation to good use.

REGISTER HERE

1 2 3 4

Search

+
Skip to content